← Alle ziektes
Kanker
Longkanker (niet-kleincellig)
Wil je bericht krijgen als er nieuw onderzoek is over Longkanker (niet-kleincellig)? Dat kan met een account. Maak een gratis account of log in.
Automatisch bijgehouden uit PubMed en ClinicalTrials.gov, nieuwste bovenaan. Er verdwijnt hier nooit iets: wat je in je favorieten bewaart, blijft vindbaar. · RSS-feed van deze ziekte · alleen het zwaarste bewijs
In gewone taal lezen waar elke studie over gaat? Met Premium staat boven elke publicatie één zin die uitlegt wat er onderzocht is — en krijg je bericht zodra er nieuw onderzoek is over Longkanker (niet-kleincellig). Bekijk wat Premium kost.
Publicaties (2593)
- Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy. (2022/12/02) ♡
- Beschrijving van enkele patiënteniHet verhaal van één of een paar patiënten. Leerzaam, maar je kunt er niet uit afleiden of iets in het algemeen werkt. A case of hepatitis induced by herbal medicine in non-small cell lung cancer patient treated by a combination of immunotherapy and chemotherapy. (2022/12/01) ♡
- IRE1α-XBP1 regulates PDK1-dependent induction of epithelial-mesenchymal transition in non-small cell lung cancer cells. (2022/12/01) ♡
- Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking. (2022/12/01) ♡
- Laboratorium- of dieronderzoekiNog geen onderzoek bij mensen. Veelbelovend in een reageerbuis of bij muizen betekent helaas nog niets voor patiënten. Aqueous Extract of Artemisia annua Shows In Vitro Antimicrobial Activity and an In Vivo Chemopreventive Effect in a Small-Cell Lung Cancer Model. (2022/12/01) ♡
- Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy. (2022/12/01) ♡
- Obesity accelerates immune evasion of non-small cell lung carcinoma via TFEB-dependent upregulation of Siglec-15 and glycolytic reprogramming. (2022/12/01) ♡
- Comparative study of TNF-α and vitamin D reveals a significant role of TNF-α in NSCLC in an ethnically conserved vitamin D deficient population. (2022/12/01) ♡
- Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H. (2022/12/01) ♡
- Intraoperative ultrasound: "Alternative eye" in lymph nodal dissection in non-small cell lung cancer. (2022/12/01) ♡
- AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models. (2022/12/01) ♡
- Chromium (VI)-induced ALDH1A1/EGF axis promotes lung cancer progression. (2022/12/01) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. [A Resected Case of Mesenteric Nodal Metastases from Small Cell Lung Carcinoma]. (2022/12/01) ♡
- Beschrijving van enkele patiënteniHet verhaal van één of een paar patiënten. Leerzaam, maar je kunt er niet uit afleiden of iets in het algemeen werkt. [A Case of Hypertrophic Pulmonary Osteoarthropathy Associated with Pulmonary Pleomorphic Carcinoma]. (2022/12/01) ♡
- OverzichtsartikeliEen samenvatting van wat er over een onderwerp bekend is, geschreven door deskundigen. Niet volgens vaste zoekregels samengesteld, dus de keuze van studies kan gekleurd zijn. Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? (2022/12/01) ♡
- Transcriptome of Lung Cancer Cells Resistant to the Cytotoxic Activity of Macrophages. (2022/12/01) ♡
- Serum circulating free DNA of syncytin-1 as a novel molecular marker for early diagnosis of non-small-cell lung cancer. (2022/12/01) ♡
- Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer. (2022/12/01) ♡
- Klinisch onderzoekiOnderzoek bij patiënten, zonder dat er geloot is tussen groepen. Bruikbaar, maar minder zeker dan een gerandomiseerd onderzoek. Combi-TED: a new trial testing Tedopi(®) with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line. (2022/12/01) ♡
- Low level of complement factor H increases the risk of cancer-related death in patients with small-cell lung cancer. (2022/12/01) ♡
- Beschrijving van enkele patiënteniHet verhaal van één of een paar patiënten. Leerzaam, maar je kunt er niet uit afleiden of iets in het algemeen werkt. Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion. (2022/12/01) ♡
- The role and mechanisms of long non-coding RNA LINC00662 in promoting the proliferation, migration, and angiogenesis of BGC-823 and HGC-27 cells and the subsequent effect on the progression of gastric cancer. (2022/12/01) ♡
- Investigation of the effects of mir-219-1 gene variants on the development of disease in non-small cell lung cancer patients. (2022/12/01) ♡
- Elucidation of the inhibitory potential of flavonoids against PKP1 protein in non-small cell lung cancer. (2022/11/30) ♡
- Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab. (2022/11/28) ♡
- Pancerebellitis Under Immunotherapy With Pembrolizumab. (2022/11/25) ♡
- Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy. (2022/11/24) ♡
- Sanguisorba officinalis L. suppresses non-small cell lung cancer via downregulating the PI3K/AKT/mTOR signaling pathway based on network pharmacology and experimental investigation. (2022/11/24) ♡
- Gerandomiseerd onderzoekiDeelnemers zijn door loting in groepen verdeeld en met elkaar vergeleken. Daardoor is de kans klein dat een verschil door iets anders komt dan de behandeling. Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling. (2022/11/24) ♡
- Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry. (2022/11/20) ♡
- An exercise prescription for patients with lung cancer improves the quality of life, depression, and anxiety. (2022/11/17) ♡
- Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients. (2022/11/17) ♡
- Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF. (2022/11/15) ♡
- Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor. (2022/11/14) ♡
- Comparison of the geriatric nutritional risk index and the prognostic nutritional index in determining survival outcome in patients with non-small cell lung cancer undergoing surgical resection: A cohort study. (2022/11/11) ♡
- Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials. (2022/11/10) ♡
- LncRNA PRRT3-AS1 exerts oncogenic effects on nonsmall cell lung cancer by targeting microRNA-507/homeobox B5 axis. (2022/11/10) ♡
- GABPB1-AS1 acts as a tumor suppressor and inhibits non-small cell lung cancer progression by targeting miRNA-566/F-box protein 47. (2022/11/10) ♡
- Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic. (2022/11/09) ♡
- Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC. (2022/11/08) ♡
- A mechanistic study on the cellular uptake, intracellular trafficking, and antisense gene regulation of bottlebrush polymer-conjugated oligonucleotides. (2022/11/08) ♡
- Environmental pathways affecting gene expression (E.PAGE) as an R package to predict gene-environment associations. (2022/11/04) ♡
- Klinisch onderzoekiOnderzoek bij patiënten, zonder dat er geloot is tussen groepen. Bruikbaar, maar minder zeker dan een gerandomiseerd onderzoek. Effect of Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway on Susceptibility to Non-Small-Cell Lung Cancer. (2022/11/04) ♡
- Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis. (2022/11/02) ♡
- Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care. (2022/11/01) ♡
- The therapeutic inhibition of topoisomerase inhibitor and crizotinib combination in EGFR wild and mutant lung cancer cells. (2022/11/01) ♡
- Pembrolizumab-associated mucous membrane pemphigoid during complete remission of metastatic non-small cell lung cancer. (2022/11/01) ♡
- Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer. (2022/11/01) ♡
- Meta-analyseiAlle studies over één vraag bij elkaar opgeteld en samen doorgerekend. Dit is de sterkste manier van onderzoeken die er bestaat: één losse studie kan toeval zijn, tientallen samen veel minder. Het etiket zegt iets over de opzet, niet over de uitkomst — die kan ook zijn dat iets níét werkt. Investigating Causal Associations of Circulating Micronutrients Concentrations with the Risk of Lung Cancer: A Mendelian Randomization Study. (2022/10/31) ♡
- Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells. (2022/10/31) ♡
codex.care geeft geen medisch advies. Bespreek klachten, medicatie en behandelkeuzes altijd met je eigen behandelaar.